Clinical Trial

A Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Suraxavir Marboxil for Suspension

Not Yet Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated August 8, 2025 (before its estimated August 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study will evaluate the safety, efficacy and pharmacokinetics of Suraxavir Marboxil compared with oseltamivir in Pediatric Patients (2 to \<12 Years) with Uncomplicated Influenza.
Trial Details
NCT Number NCT07113392
Lead Sponsor Jiangxi Kvvit Pharmaceutical Co., Ltd.
Conditions Influenza
Enrollment 144 participants
Start Date 2025-08-01
Primary Completion 2026-08-01 (estimated)
Study Completion 2026-08-01 (estimated)
Updated on ClinicalTrials.gov 2025-08-08